Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
ZYDUSLIFE Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Strong price momentum
Analysts have been raising forward EPS estimates
High and stable ROE
High and stable operating margin
Moderate revenue growth and above median growth of industry
Moderate EPS growth and above median growth of industry
Consistently pays dividend
Negative
Not enough talking point with negative stance
Neutral
Low Debt to Equity but increasing
Company's earnings are of moderate quality
Moderate dividend yield
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
ZYDUSLIFE Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
ZYDUSLIFE Bulk, Block & Insider Trades
ZYDUSLIFE Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Stock split
Others
Bonus(1 new shares for 2 existing shares)BOD 25 February 2010. EGM 22 March 2010. Ex-date: 5th Apr 2010 Announced on: 25th Feb 2010
Bonus(1 new shares for 1 existing shares)Bonus issue of 62806854 securities Ex-date: 30th Aug 2006 Announced on: 28th Apr 2006
Stock split(1 : 5)Nominal value change from INR 5 to INR 1. Ex-date: 6th Oct 2015 Announced on: 12th Aug 2015
Share Buyback"On Market Tender Offer." Ex-date: 23rd Feb 2024 Announced on: 9th Feb 2024
Share BuybackOn market Tender offer. Ex-date: 1st Jun 2022 Announced on: 20th May 2022
Demerger (DEM)"Demerger of Consumer Products Division (CPD) from the Company into Carnation Nutra Analogue Foods Limited (Carnation). As a consideration Carnation shall allot to the shareholders of Cadila Healthcare 4 equity shares of Rs 10 each for every 15 shares of Rs 5 each held in Cadila healthcare." Ex-date: 29th Dec 2008 Announced on: 4th Jul 2008
MergerEquity shares alloted to the erstwhile shareholders of German Remedies Ltd. Recon Healthcare Ltd. Zyds Pathline Ltd. and Zoom Properties with Cadila Healthcare Ltd. Ex-date: 5th Sep 2003 Announced on: 25th Aug 2003
Company Profile
Zydus Lifesciences Limited is an India-based global life sciences company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The Company is engaged in the business of integrated pharmaceutical operations. Its product portfolio includes active pharmaceutical ing... Read More
Key personnel
Shri. Pankaj Ramanbhai PatelD
Non-Executive Chairman of the Board
Mr. Tushar Shroff
Chief Financial Officer
Mr. Dhaval Narendra Soni
Company Secretary, Compliance Officer
Sharvil Pankajbhai PatelD
Managing Director, Executive Director
Mr. Ganesh N. NayakD
Executive Director
Mr. Mukesh Mangalbhai PatelD
Non-Executive Director
Shri. Apurva S. DiwanjiD
Non-Executive Independent Director
Ms. Upasana Kamineni KonidelaD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Zydus Lifesciences Ltd.?
The current share price of Zydus Lifesciences Ltd. is ₹ 894.92 as of 09 Jan 2026.
What is the PE ratio of Zydus Lifesciences Ltd.?
The Price-to-Earnings (PE) ratio of Zydus Lifesciences Ltd. is 18.30 as of the latest financial data.
What is the ROE and ROCE of Zydus Lifesciences Ltd.?
Zydus Lifesciences Ltd. has a Return on Equity (ROE) of 20.88% and a Return on Capital Employed (ROCE) of 19.32% as per the latest financial reports.
What is the market cap of Zydus Lifesciences Ltd.?
The market capitalization of Zydus Lifesciences Ltd. stands at ₹ 90,049.90 Cr.
What is the dividend yield of Zydus Lifesciences Ltd.?
The dividend yield of Zydus Lifesciences Ltd. is 1.23% based on the current market price.
What is the RSI of Zydus Lifesciences Ltd.?
The Relative Strength Index (RSI) of Zydus Lifesciences Ltd. is 35.94.
What is the FII and DII holding in Zydus Lifesciences Ltd.?
Foreign Institutional Investors (FII) hold 7.06% and Domestic Institutional Investors (DII) hold 10.85% of Zydus Lifesciences Ltd. shares.
What sector does Zydus Lifesciences Ltd. belong to?
Zydus Lifesciences Ltd. operates in the Healthcare sector.
What is the beta of Zydus Lifesciences Ltd. stock?
The beta of Zydus Lifesciences Ltd. stock is 0.90, indicating its volatility relative to the broader market.
